Methotrexate efficiency for treatment of corticosteroid-dependent asthmatic patients;Eficacia del metotrexato en el tratamiento de pacientes asmaticos corticodependientes

Revista Clinica Espanola

Volumn 199, Issue 3, 1999, Pages 142-146

  Domingo Ribas, Ch ^a,c   Comet Monte, R ^a   Bosque Garcia M ^a   Moron Besoli A ^b   Monton Soler C ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b Servicio de Farmacia   (Spain)

^c Hospital Universitari Parc Taulí   (Spain)

Author keywords

Corticosteroid dependent bronchial asthma; Methotrexate

Indexed keywords

CORTICOSTEROID; DEFLAZACORT; METHOTREXATE; METHYLPREDNISOLONE;

ADULT; AGED; ARTICLE; ASTHMA; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CORTICOSTEROID THERAPY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; HERPES LABIALIS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; LUNG FUNCTION; MALE; ORAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ASTHMA; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHOTREXATE; METHYLPREDNISOLONE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 0033046239     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. National Heart, Lung and Blood Institute. International consensus report on diagnosis and management of asthma. US Eur Respir J 1992; 5:601-641.
2. Suárez C, Pickett W, Bell D, McClintock D, Oronsky A, Kerwar S. Effect of low dose methotrexate on neutrophil chemotaxis induced by leukotriene B4 and complement C5a. J Rheumatol 1987; 14:9-11.
3. Hu SK, Mitcho Y, Oronsky A, Kerwar S. Studies on the effect of methotrexate on macrophage function. J Rheumatol 1988; 15:206-209.
4. Nolte H, Skov P. Inhibition of basophil histamine release by methotrexate. Agents Actions 1988; 23:173-176.
5. Mullarkey MF, Webb DR, Pardee NE. Methotrexate in the treatment of steroid-dependent asthma. Ann Allergy 1986; 56:347-350.
6. Mullarkey MF, Blumenstein BA, Andrade WP, Bailey GA, Olason I, Wetzel CE. Methotrexate in the treatment of corticosteroid-dependent asthma. N Engl J Med 1988; 318:603-607.
7. Mullarkey MF, Lammert JK, Blumenstein BA. Long-term methotrexate treatment in corticosteroid-dependent asthma. Ann Intern Med 1990; 112:577-581.
8. Roca J, Sanchis J, Agustí-Vidal A, et al. Spirometric reference values from a mediterranean population. Bull Eur Physiopathol Respir 1986; 22:217-224.
9. Roca J, Segarra F, Rodríguez Roisin R, Cobo E, Martínez J, Agustí-Vidal A. Static lung volumes and single-breath diffusing capacity. Reference values from a latin population (abstract). Am Rev Respir Dis 1985; 131:A352.
10. Roca J, Rodríguez-Roisin R, Cobo E, Burgos F, Pérez J, Clausen JL. Single-breath carbon monoxide diffusing capacity prediction equations from a mediterranean population. Am Rev Respir Dis 1990; 141:1.026-1.032.
11. Coffey MJ, Sanders G, Eschenbacher WL, et al. The role of methotrexate in the management of steroid-dependent asthma. Chest 1994; 105:117-121.
12. Shiner RJ, Nunn AJ, Chung KF, Geddes DM. Randomized, double-blind, palcebo-controlled trial of methotrexate in steroid-dependent asthma. Lancet 1990; 336:137-140.
13. Dyer PD, Vaughan TR, Weaver RW. Methotrexate in the treatment of steroid dependent asthma. J Allergy Clin Immunol 1991; 88:208-212.
14. Stewart GE, Díaz JD, Lockey RF, Seleznick MJ, Trudeau WL, Leford DK. Comparison of oral pulse methotrexate with placebo in the treatment of severe glucocorticosteroid-dependent asthma. J Allergy Clin Immunol 1994; 94 (3 Pt 1):482-489.
15. Erzurum SC, Leff JA, Cochram JE, et al. Lack of benefit of methotrexate in severe, steroid-dependent asthma, a double-blind, placebo-controlled study. Ann Intern Med 1992; 114:353-360.
16. Taylor DR, Flannery EM, Herbison GP. Methotrexate in the management of severe steroid dependent asthma. NZ Med J 1993;106:409-411.
17. Marin MG. Low-dose methotrexate spares steroid usage in steroid-dependent asthmatic patients. Chest 1997; 112:29-33.